锦好医疗
(920925)
| 流通市值：6.21亿 | | | 总市值：11.00亿 |
| 流通股本：5562.97万 | | | 总股本：9858.06万 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 105,680,614.14 | 41,924,051.86 | 307,521,692.87 | 195,653,829.77 |
| 营业收入 | 105,680,614.14 | 41,924,051.86 | 307,521,692.87 | 195,653,829.77 |
| 二、营业总成本 | 113,454,456.02 | 49,206,673.72 | 287,329,520.29 | 178,671,183.5 |
| 营业成本 | 59,613,965.44 | 23,147,230.52 | 192,044,848.22 | 112,364,831.71 |
| 税金及附加 | 1,858,268.92 | 1,025,380.42 | 2,610,933.79 | 1,156,468.65 |
| 销售费用 | 26,595,649.78 | 12,826,199.06 | 48,526,831.22 | 34,302,942.95 |
| 管理费用 | 12,027,751.43 | 5,631,355.2 | 20,627,379.03 | 14,266,489.01 |
| 研发费用 | 9,350,955.3 | 4,715,075.26 | 21,186,441.1 | 15,557,247.35 |
| 财务费用 | 4,007,865.15 | 1,861,433.26 | 2,333,086.93 | 1,023,203.83 |
| 其中:利息费用 | 106,275.08 | 24,570.89 | 843,811.16 | 606,469.32 |
| 其中:利息收入 | 212,278.15 | 66,693.01 | 1,210,080.31 | 1,109,833.82 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 178,219.18 | 139,173.15 | 10,218.63 | 53,123.29 |
| 加:投资收益 | 951,284.96 | 50,420.05 | 432,428.15 | 83,617.94 |
| 资产处置收益 | 88,090.95 | 83,060.61 | 150,784.58 | 50,002.16 |
| 资产减值损失(新) | -541,667.1 | -33,715.19 | -5,255,550.04 | -823,294.66 |
| 信用减值损失(新) | 968,324.45 | 618,794.52 | -2,386,729.86 | -481,257.94 |
| 其他收益 | 93,382.03 | 79,078.61 | 2,517,524.48 | 1,493,570.45 |
| 四、营业利润 | -6,036,207.41 | -6,345,810.11 | 15,660,848.52 | 17,358,407.51 |
| 加:营业外收入 | 571,135 | 52,576.13 | 2,054,389.96 | 1,979,765.49 |
| 减:营业外支出 | 476,233.96 | 70,536.97 | 144,279.77 | 38,674.45 |
| 五、利润总额 | -5,941,306.37 | -6,363,770.95 | 17,570,958.71 | 19,299,498.55 |
| 减:所得税费用 | 768,809.69 | 848,529.87 | 2,783,458.04 | 3,076,634.34 |
| 六、净利润 | -6,710,116.06 | -7,212,300.82 | 14,787,500.67 | 16,222,864.21 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -6,710,116.06 | -7,212,300.82 | 14,787,500.67 | - |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -5,976,428.92 | -6,695,858.34 | 15,358,862.15 | 17,630,163.28 |
| 少数股东损益 | -733,687.14 | -516,442.48 | -571,361.48 | -1,407,299.07 |
| 扣除非经常损益后的净利润 | -7,019,196.8 | -7,156,019.8 | 12,764,299.8 | 15,192,586.59 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.06 | -0.07 | 0.16 | 0.18 |
| (二)稀释每股收益 | -0.06 | -0.07 | 0.16 | 0.18 |
| 八、其他综合收益 | 1,077,360.41 | 922,318.76 | -838,276.61 | -7,913.04 |
| 归属于母公司股东的其他综合收益 | 1,077,360.41 | 922,318.76 | -838,276.61 | -7,913.04 |
| 九、综合收益总额 | -5,632,755.65 | -6,289,982.06 | 13,949,224.06 | 16,214,951.17 |
| 归属于母公司股东的综合收益总额 | -4,899,068.51 | -5,773,539.58 | 14,520,585.54 | 17,622,250.24 |
| 归属于少数股东的综合收益总额 | -733,687.14 | -516,442.48 | -571,361.48 | -1,407,299.07 |
| 公告日期 | 2026-08-25 | 2026-04-29 | 2026-04-21 | 2025-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |